215 related articles for article (PubMed ID: 19583452)
21. Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.
Derom E; Pauwels RA
Clin Pharmacokinet; 2005; 44(8):815-36. PubMed ID: 16029067
[TBL] [Abstract][Full Text] [Related]
22. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
23. Oral beclomethasone dipropionate in gastrointestinal graft-versus-host disease.
Hockenbery DM
Expert Rev Clin Immunol; 2007 Sep; 3(5):695-700. PubMed ID: 20477020
[TBL] [Abstract][Full Text] [Related]
24. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.
Weisdorf DJ; Snover DC; Haake R; Miller WJ; McGlave PB; Blazar B; Ramsay NK; Kersey JH; Filipovich A
Blood; 1990 Aug; 76(3):624-9. PubMed ID: 2378989
[TBL] [Abstract][Full Text] [Related]
25. Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.
Chien JW; Sakai M; Gooley TA; Schoch HG; McDonald GB
Bone Marrow Transplant; 2010 Feb; 45(2):317-24. PubMed ID: 19561649
[TBL] [Abstract][Full Text] [Related]
26. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
Drugs; 1975; 10(3):166-210. PubMed ID: 172309
[TBL] [Abstract][Full Text] [Related]
27. Preparation of enteric-coated capsules of beclomethasone dipropionate for patients with intestinal graft-versus-host disease and a case study.
Murakawa K; Sato T; Maeda Y; Kitamura Y; Tanimoto M; Sendo T
Acta Med Okayama; 2013; 67(5):319-24. PubMed ID: 24145732
[TBL] [Abstract][Full Text] [Related]
28. Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation.
Krishna SG; Barlogie B; Lamps LW; Krishna K; Aduli F; Anaissie E
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):E17-21. PubMed ID: 20223723
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
[TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
Nicolini G; Cremonesi G; Melani AS
Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.
Roy J; Snover D; Weisdorf S; Mulvahill A; Filipovich A; Weisdorf D
Transplantation; 1991 Mar; 51(3):642-6. PubMed ID: 2006521
[TBL] [Abstract][Full Text] [Related]
32. Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.
Daniel F; Hassoun L; Husni M; Sharara A; Soweid A; Barada K; Haffar B; Massoud R; Shaib Y; Al-Hashash J; Bazarbachi A; El Cheikh J
Curr Res Transl Med; 2019 Feb; 67(1):16-19. PubMed ID: 30206046
[TBL] [Abstract][Full Text] [Related]
33. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Ganetsky A; Frey NV; Hexner EO; Loren AW; Gill SI; Luger SM; Mangan JK; Martin ME; Babushok DV; Drobyski WR; Smith J; Timlin C; Freyer CW; Stadtmauer EA; Porter DL
Bone Marrow Transplant; 2019 Feb; 54(2):212-217. PubMed ID: 29795429
[TBL] [Abstract][Full Text] [Related]
34. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
35. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
Holmberg L; Kikuchi K; Gooley TA; Adams KM; Hockenbery DM; Flowers ME; Schoch HG; Bensinger W; McDonald GB
Biol Blood Marrow Transplant; 2006 Feb; 12(2):226-34. PubMed ID: 16443520
[TBL] [Abstract][Full Text] [Related]
39. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
Cross RK
Inflamm Bowel Dis; 2017 Oct; 23(10):1689-1701. PubMed ID: 28906290
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
